Who Paid My Doc
Spevigo
Drug Immunology
NDC 0597-0035-10
General payments
$3,193,018
Research payments
$14,314,416
Through program year 2025, $3,193,018 in general payments and $14,314,416 in research payments were reported against Spevigo (Immunology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $735,121 | 4,986 |
| 2025 | Research | $1,977,738 | 773 |
| 2024 | General | $1,289,773 | 9,252 |
| 2024 | Research | $11,181,114 | 101 |
| 2023 | General | $1,052,664 | 7,577 |
| 2022 | General | $115,460 | 2,700 |
| 2022 | Research | $1,155,564 | 77 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 59 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
24,515 general · 951 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.